In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Biosite Diagnostics and Ixsys entered into two-year agreement

Executive Summary

Biosite Diagnostics and Ixsys (both developing monoclonal antibodies) have entered into a two-year research and development agreement, which includes the exchange of certain proprietary technologies.
Deal Industry
  • In Vitro Diagnostics
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Contract
    • Product or Technology Swap
    • R+D and Marketing-Licensing
    • Intra-Biotech Deal

Related Companies